This CAST literature review and report looks at problems caused by the current system of asynchronous approvals for biotech crops. The authors focus on the economic effects in countries that are major global commodity exporters and importers, which show that asynchrony in the global approval of new biotech crops and the resultant risk of low level presence (LLP) puts large volumes of trade worth billions of dollars at risk.
The Trump administration will attack overseas regulations that restrict the export of GMO crops and other products resulting from American technological innovation, said U.S. Trade Representative Robert Lighthizer at the first meeting of a newly created interdepartmental task force on rural America. Read moreRead More »
Precision gene editing in plants is a way for scientists and researchers to increase nutritional value and decrease susceptibility to diseases. Plant breeders want all the tools in the tool box to make quick efficient changes, and gene editing is another instrument. Read moreRead More »